Search companies or stocks...
LGNDLigand Pharmaceuticals Incorporated
At close · 01 Sept 2026, 08:00 pm
Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop…
Current stock price of Ligand Pharmaceuticals Incorporated (LGND) stock is $284.27. The stock price is +0.06% higher in the session. The intraday range can be seen from this page. Volume of Ligand Pharmaceuticals Incorporated (LGND) stock is 185.02K.
Last updated at 01 Sept 2026, 08:00 pm.
The stock price of Ligand Pharmaceuticals Incorporated (LGND) can change with earnings, company news, and overall market sentiment. Ligand Pharmaceuticals Incorporated operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.
Whether Ligand Pharmaceuticals Incorporated looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for LGND on this page is 31.20. EPS on this page is 9.11. Compare those figures with peers and growth expectations before deciding if the current Ligand Pharmaceuticals Incorporated price is justified.
Historical performance for Ligand Pharmaceuticals Incorporated (LGND) is shown on the price chart on this page. Review multi-period moves alongside volume to see how LGND reacted to past earnings and market events.
Buying Ligand Pharmaceuticals Incorporated (LGND) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.
